Nationwide Fund Advisors’s Utah Medical Products UTMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-12,071
Closed -$888K 2013
2017
Q3
$888K Buy
12,071
+4,300
+55% +$309K ﹤0.01% 1867
2017
Q2
$563K Hold
7,771
﹤0.01% 2118
2017
Q1
$484K Sell
7,771
-170
-2% -$10.7K ﹤0.01% 2172
2016
Q4
$578K Sell
7,941
-196
-2% -$12.7K ﹤0.01% 2100
2016
Q3
$487K Sell
8,137
-1,100
-12% -$70K ﹤0.01% 2193
2016
Q2
$582K Sell
9,237
-1,500
-14% -$96.7K ﹤0.01% 2070
2016
Q1
$671K Sell
10,737
-176
-2% -$10.4K ﹤0.01% 1930
2015
Q4
$639K Buy
10,913
+1,400
+15% +$79.4K ﹤0.01% 1983
2015
Q3
$512K Buy
9,513
+6,930
+268% +$378K ﹤0.01% 2104
2015
Q2
$154K Sell
2,583
-193
-7% -$10.9K ﹤0.01% 2849
2015
Q1
$166K Sell
2,776
-87
-3% -$5.12K ﹤0.01% 2781
2014
Q4
$172K Buy
2,863
+39
+1% +$2.16K ﹤0.01% 2708
2014
Q3
$138K Buy
2,824
+47
+2% +$2.39K ﹤0.01% 2868
2014
Q2
$143K Buy
2,777
+245
+10% +$12.6K ﹤0.01% 2905
2014
Q1
$146K Hold
2,532
﹤0.01% 2623
2013
Q4
$145K Sell
2,532
-99
-4% -$5.43K ﹤0.01% 2828
2013
Q3
$156K Buy
2,631
+149
+6% +$8.13K ﹤0.01% 2781
2013
Q2
$135K Buy
+2,482
New +$117K ﹤0.01% 2674

Other funds holding UTMD

Nationwide Fund Advisors's UTMD Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Utah Medical Products (UTMD) in Q4 2017, closing a stake of 12,071 shares — an estimated $888K sold.

Nationwide Fund Advisors first reported a position in UTMD in Q2 2013 and held it in 18 quarters. The position peaked at $888K in Q3 2017. 78 funds tracked by Wall St. Rank hold UTMD as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Utah Medical Products position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 12,071 Utah Medical Products shares in Q4 2017, an estimated $888K.
  • Nationwide Fund Advisors first reported a position in Utah Medical Products in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's Utah Medical Products position peaked at $888K in Q3 2017.
  • 78 funds tracked by Wall St. Rank held Utah Medical Products as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.